0000905718-16-001790.txt : 20161129 0000905718-16-001790.hdr.sgml : 20161129 20161129164629 ACCESSION NUMBER: 0000905718-16-001790 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161129 DATE AS OF CHANGE: 20161129 EFFECTIVENESS DATE: 20161129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-275294 FILM NUMBER: 162023216 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 D 1 primary_doc.xml X0707 D LIVE 0000744218 Celldex Therapeutics, Inc. 53 FRONTAGE ROAD, SUITE 220 HAMPTON NJ NEW JERSEY 08827 908-200-7500 DELAWARE None AVANT IMMUNOTHERAPEUTICS INC T CELL SCIENCES INC Corporation true Herbert J. Conrad c/o Celldex Therapeutics Inc. 53 Frontage Road, Suite 220 Hampton NJ NEW JERSEY 08827 Director Larry Ellberger c/o Celldex Therapeutics Inc. 53 Frontage Road, Suite 220 Hampton NJ NEW JERSEY 08827 Director George O. Elston c/o Celldex Therapeutics Inc. 53 Frontage Road, Suite 220 Hampton NJ NEW JERSEY 08827 Director Karen Shoos c/o Celldex Therapeutics Inc. 53 Frontage Road, Suite 220 Hampton NJ NEW JERSEY 08827 Director Anthony S. Marucci c/o Celldex Therapeutics Inc. 53 Frontage Road, Suite 220 Hampton NJ NEW JERSEY 08827 Executive Officer Director Harry H. Penner, Jr. c/o Celldex Therapeutics Inc. 53 Frontage Road, Suite 220 Hampton NJ NEW JERSEY 08827 Director Richard van den Broek c/o Celldex Therapeutics Inc. 53 Frontage Road, Suite 220 Hampton NJ NEW JERSEY 08827 Director Avery W. Catlin c/o Celldex Therapeutics Inc. 53 Frontage Road, Suite 220 Hampton NJ NEW JERSEY 08827 Executive Officer Biotechnology Decline to Disclose 06b false 2016-11-29 false true true At closing our wholly owned subsidiary merged with and into Kolltan Pharmaceuticals, Inc. and Kolltan became our whollyowned subsidiary. Kolltan's investors received 18,257,996 shares of our stock. 0 62500000 62500000 0 Excludes milestone payments of up to $172.5 million which may be made in cash or shares or a combination thereof. false 29 0 0 0 true false Celldex Therapeutics, Inc. /s/ Avery W. Catlin Avery W. Catlin Senior Vice President, CFO 2016-11-29